Esketamine: Depression's Journey From Monoamines to Glutamate Psychiatric TimesPsychiatry has finally crossed into a new paradigm in the treatment of TRD, bringing the glutamate system on board to join the modulation of the monoamine ...
Using Esketamine Nasal Spray for Treatment Resistant Depression MD MagazineA study presented at APA 2019 found that esketamine spray to be an effective, fast-acting treatment for people with treatment-resistant depression.
Cannes Review: 'Little Joe' Blooms a Sterile World with a Muddled Conceit The Film StageJessica Hausner's English-language debut Little Joe promises a crossbreed of shrewd science fiction and health care satire, but it scuppers its genre creds in.
Esketamine nasal spray plus antidepressant effective for hard-to-treat depression HealioSAN FRANCISCO — Patients with treatment-resistant depression saw clinically meaningful and statistically significant improvement in depressive symptoms at ...
Antidepressant withdrawal guidance must be updated to reflect evidence The BMJBMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l2283 (Published 21 May 2019) Cite this as: BMJ 2019;365:l2283. Article; Related *content*; Metrics; Responses ...
Trump plan could deprive seniors of lifesaving medicines Corpus Christi Caller-TimesThe administration wants to allow insurers to stop covering certain medicines and impose restrictions on the medications they do cover.
New Data Highlights the Value of SPRAVATO™ (esketamine) CIII Nasal Spray, the First New Antidepressant in Decades that Works Differently for Adults with Treatment-Resistant Depression (TRD) Yahoo FinanceNEW ORLEANS, May 21, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson presented a new cost-efficiency analysis at the ...
New Data Highlights the Value of SPRAVATO™ (esketamine) CIII Nasal Spray, the First New Antidepressant in Decades that Works Differently for Adults with Treatment-Resistant Depression (TRD)[1] PRNewswireNEW ORLEANS, May 21, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson presented a new co
'Drugs take everything from you': Haledon woman makes a comeback as fine-dining pasta chef NorthJersey.comLess than three years ago, Joyann Demont didn't have a job, a home or her kids. She was a drug addict living on the streets of Paterson.
First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA Yahoo FinanceRacemic sublingual ketamine, Wafermine, is the first sublingual ketamine drug seeking FDA approval for the treatment of moderate to severe acute pain ...
